Status:
COMPLETED
Individual Versus Standard Follicle Stimulating Hormone Dose for Controlled Ovarian Stimulation and Insemination
Lead Sponsor:
Nina la Cour Freiesleben
Conditions:
Infertility
Eligibility:
FEMALE
25-39 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to test if recombinant follicle stimulating hormone (rFSH) given in individual doses, according to a nomogram we have constructed based on our results from a previous stud...
Eligibility Criteria
Inclusion
- Age between 25-39 years
- First stimulation with rFSH only
- Indication for intrauterine insemination with standard rFSH starting dose
- Regular menstrual bleeding with a cycle between 21-35 days
- Two ovaries
- Bilateral tuba patency
- Semen analysis must be sufficient for insemination according to the diagnostic analysis.
Exclusion
- More than three former stimulated intrauterine insemination cycles
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
234 Patients enrolled
Trial Details
Trial ID
NCT00374634
Start Date
September 1 2006
End Date
October 1 2008
Last Update
October 3 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fertility Clinic, dep.4071, Copenhagen University Hospital, Rigshospitalet
Copenhagen East, Denmark, 2100